Hematologic Neoplasms: all 1,494 studies
Page 13 of 15. Open to participants first (438), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic MalignanciesCompletedNCT02305979
- Analysis of T Cell and Natural Killer (NK) Cell in Relation to Viral Infections in Pediatric Stem Cell Transplant Patients and DonorsCompletedNCT02301065
- Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell TransplantStatus unknownNCT02300571
- B-Cell Hematologic Malignancy Vaccination RegistryWithdrawnNCT02298816
- Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic MalignanciesCompletedNCT02270788Phase 1
- Study Evaluating Venetoclax in Subjects With Hematological MalignanciesCompletedNCT02265731Phase 1/2
- Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic CancerStatus unknownNCT02240537Phase 1
- A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological MalignanciesTerminatedNCT02223598Phase 1
- Therapy for Progressive and/or Refractory Hematologic MalignanciesWithdrawnNCT02223312Phase 1/2
- Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCompletedNCT02223052Phase 1
- Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic AnalysisStatus unknownNCT02213822
- Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus InfectionActive, not recruitingNCT02210078Phase 2
- Reiki as a Complementary Therapy: A Pilot StudyWithdrawnNCT02207764Not applicable
- The Good Patient StudyCompletedNCT02199548
- Physiotherapy in Hematopoietic Stem Cell TransplantationStatus unknownNCT02193399Not applicable
- Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor SourceCompletedNCT02167958Phase 1
- Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological MalignanciesCompletedNCT02164071
- Dose Escalation Study of LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic MalignanciesCompletedNCT02160951Phase 1
- Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUOCompletedNCT02149329Phase 4
- Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02129582Phase 1
- Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesCompletedNCT02122081Phase 1
- Treg Cells for AGVHD in Non-myeloablative UCB TransplantWithdrawnNCT02118311Phase 2
- Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological MalignanciesCompletedNCT02106650Phase 2
- Medical-legal Partnership (MLP) to Support Bone Marrow TransplantWithdrawnNCT02087787Not applicable
- Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell DepletionWithdrawnNCT02053545Phase 1/2
- Observational Study in Patients Who Underwent an Haploidentical Transplantation With T-repleted Bone MarrowTerminatedNCT02049424
- Safety of Romiplostim (Nplate®) Following UCBTCompletedNCT02046291Phase 1
- Technology to Assess Vulnerable Older Adults With Cancer and Their CaregiversActive, not recruitingNCT02041416
- Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1CompletedNCT02034981Phase 2
- Comprehensive Frailty AssessmentCompletedNCT02033928
- Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host DiseaseStatus unknownNCT02032446Phase 1/2
- Secondary Haplo HSCT for Relapse After Initial Allogeneic HSCTCompletedNCT01997918
- Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood TransplantationStatus unknownNCT01983761Phase 1/2
- Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of LifeCompletedNCT01930981
- Hepatosplenic CANdidiasis : PETscan and Immune Response AnalysisCompletedNCT01916057Not applicable
- Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological MalignanciesStatus unknownNCT01915992Not applicable
- Phase 1 Study of CC-486 in Japanese Subjects With Hematological NeoplasmsTerminatedNCT01908387Phase 1
- Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic MalignanciesCompletedNCT01900509Phase 1
- Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell TransplantationWithdrawnNCT01882387Phase 2
- Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood TransplantationWithdrawnNCT01882374Phase 2
- Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized TherapyCompletedNCT01869218
- Quality of Life in Caregivers of Hospitalized Older Patients With CancerCompletedNCT01866969Not applicable
- PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous ThromboembolismCompletedNCT01855698
- P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic MalignanciesCompletedNCT01854567Phase 3
- Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell TransplantationCompletedNCT01853358Phase 1
- Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related PainTerminatedNCT01846429Phase 1
- An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine MepesuccinateCompletedNCT01844869Phase 1
- Evaluation of PET/MRI in Children with CancerCompletedNCT01839747Not applicable
- A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological MalignanciesCompletedNCT01830010Phase 1
- Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell TransplantCompletedNCT01822509Phase 1
- Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological PatientsTerminatedNCT01820962Phase 3
- Phase I/II Study of Treg/Tcon Addback to Partially Matched Related Donor Stem Cells With Myeloablative Conditioning and Post-transplant Cyclophosphamide for High Risk Hematologic MalignanciesTerminatedNCT01818479Phase 1
- Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood SamplesWithdrawnNCT01792882
- Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell TransplantationStatus unknownNCT01788605Phase 2
- Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic MalignanciesCompletedNCT01767766Phase 1
- Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell TransplantCompletedNCT01758484Not applicable
- Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood TransplantationStatus unknownNCT01757145Phase 2
- Study of Hypotensive Hematopoietic Malignancy Patients' USCOM ReadingsCompletedNCT01755000Not applicable
- Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological MalignanciesWithdrawnNCT01751243Phase 1
- Scripps Tumorgraft StudyCompletedNCT01726699
- A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant TumorsCompletedNCT01725555Phase 1
- A Controlled Study of Stem Cell Transplantation Medical Home Care Compared to Standard Hospital CareCompletedNCT01725022Not applicable
- Effect of Body Mass on Filgrastim PharmacokineticsCompletedNCT01719432
- Study of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies or Acquired Aplastic AnaemiaStatus unknownNCT01719341
- Effect of Body Mass on Acyclovir PharmacokineticsCompletedNCT01714180
- Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic DietsCompletedNCT01687231Not applicable
- Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic MalignanciesCompletedNCT01658319Phase 1
- Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic MalignanciesTerminatedNCT01643603Phase 1
- Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological MalignanciesCompletedNCT01635712Phase 1
- Donor Cord Blood T-Cell Infusion After Stem Cell Transplant in Treating Patients With Relapsed Hematological MalignanciesTerminatedNCT01630564Phase 1
- The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.TerminatedNCT01627314Phase 2
- Naive T-Cell Depleted DLI Following Allo Stem Cell TransplantCompletedNCT01627275Phase 1
- Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic MalignanciesTerminatedNCT01622556Phase 2
- Brentuximab Vedotin After Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWithdrawnNCT01620229Phase 1/2
- Intra-bone Cord Blood Transplantation in Patients With Haematological MalignanciesStatus unknownNCT01613066Phase 1/2
- Study of Stress and Life Quality of Patients Participating in Clinical Trials Versus Patients Non ParticipatingCompletedNCT01606033Not applicable
- Trial of Haploidentical Stem Cell Transplantation for Haematological CancersCompletedNCT01597219Phase 2
- A Study of LY2784544 in Participants With Myeloproliferative NeoplasmsActive, not recruitingNCT01594723Phase 2
- Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BALCompletedNCT01576653Not applicable
- Study of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning RegimensCompletedNCT01572181Phase 2
- Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood TransplantationWithdrawnNCT01554254Phase 2
- Phase I Study of mPEG-R-Crisantaspase Given IVCompletedNCT01551524Phase 1
- Neutrophil Extracellular Traps (NETs) Formation Following Chemotherapy and Their Role in Antitumor ActivityStatus unknownNCT01533779
- Study Comparing G-CSF Mobilized Peripheral Blood and G-CSF Stimulated Bone Marrow in Patients Undergoing Matched Sibling TransplantationCompletedNCT01530581Phase 3
- Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchTerminatedNCT01500161Phase 2
- Biomarker Research for Personalized MedicineStatus unknownNCT01488591
- Umbilical Cord Transplantation for the Elderly PopulationCompletedNCT01484470Phase 2
- A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic MalignanciesTerminatedNCT01476657Phase 1
- Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic MalignanciesCompletedNCT01471067Phase 1
- Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic TransplantationCompletedNCT01460420Phase 1/2
- Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic MalignancyWithdrawnNCT01452334Phase 1
- A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple MyelomaWithdrawnNCT01445587Phase 2
- Diagnosing Pulmonary Aspergillosis in Patients With Hematological Malignancies: A Multicentre Prospective Evaluation of an Aspergillus PCR Assay and a Galactomannan ELISA in Bronchoalveolar Lavage SamplesCompletedNCT01430663
- Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis RegimensActive, not recruitingNCT01428973Phase 2
- Study With SAR302503 in Patients With Polycythemia Vera or Essential ThrombocythemiaCompletedNCT01420783Phase 2
- Phase 2 Study of SAR302503 in Patients With MyelofibrosisCompletedNCT01420770Phase 2
- Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic MalignanciesTerminatedNCT01416428Phase 1/2
- Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological MalignanciesCompletedNCT01399840Phase 1
- Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid LeukemiaCompletedNCT01380756Phase 1
- A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid TumorsCompletedNCT01375842Phase 1